z-logo
open-access-imgOpen Access
Estrogen receptor β agonist inhibits proliferation of endometrial stromal cells in an estrogen-receptor independent manner
Author(s) -
Qiong Xia,
Dong Zhao,
Juan Wang
Publication year - 2014
Publication title -
archives of biological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 25
eISSN - 1821-4339
pISSN - 0354-4664
DOI - 10.2298/abs1402735x
Subject(s) - stromal cell , estrogen receptor , agonist , estrogen , endocrinology , medicine , endometrium , endometriosis , estrogen receptor beta , receptor , stroma , progesterone receptor , ectopic expression , chemistry , cancer research , biology , cell culture , immunohistochemistry , cancer , genetics , breast cancer
The finding that estrogen receptor ERβ agonists induce regression of ectopic endometrial implants in a rodent model has rekindled interest in the role of ERβ in the growth and maintenance of human endometriosis. We hypothesize that the ERβ agonist may have a direct effect on the human endometrium. We examined the mRNA and protein expression of ERβ in both eutopic and ectopic endometrium and performed a luciferase reporter assay for the presence of functional ERβ in human endometrial stromal cells. Diarylpropionitrile (DPN - a ERβ specific agonist) significantly inhibited endometrial stromal cell proliferation at 10 M by 25% but not at 10 nM. ERβ mRNA is present in both eutopic and ectopic endometrium; however, protein expression is absent in both stroma and epithelium. Our search for functional ERβ similarly showed an absence in endometrial stromal cells. These results suggest that the regression of endometriosis might be ERβ-independent

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom